Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis

CompletedOBSERVATIONAL

Enrollment

370

Participants

Timeline

Start Date

January 1, 2007

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Inflammatory Bowel Disease

Interventions

OTHER

No intervention

This is an observational study. Patients receiving infliximab or anti-TNF as per the prescribing information will be observed.